Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Reexamination Certificate
2007-11-20
2007-11-20
Maier, Leigh C. (Department: 1623)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
C424S445000, C514S008100, C514S056000
Reexamination Certificate
active
10684022
ABSTRACT:
A wound dressing, method of making, and method of use, utilizing a polymeric film having complexed thereto by hydrophobic interaction a construct including a polyanion covalently bonded to a hydrophobic prosthetic moiety, with one or more bioactive molecules directly complexed to the polyanion. The polyanion may be heparin or a heparin-activity molecule. The prosthetic group may include a hydrophobic silyl-containing moiety. Bioactive molecules include adhesive molecules, growth factor molecules, and therapeutic molecules, including antibiotics.
REFERENCES:
patent: 5147339 (1992-09-01), Sundstrom
patent: 5667810 (1997-09-01), Levin
patent: 5807295 (1998-09-01), Hutcheon et al.
patent: 5876730 (1999-03-01), Brigstock et al.
patent: 5902798 (1999-05-01), Gouda et al.
patent: 5906828 (1999-05-01), Cima et al.
patent: 5955588 (1999-09-01), Tsang et al.
patent: 6245753 (2001-06-01), Byun et al.
patent: 6342591 (2002-01-01), Zamora et al.
patent: 6486140 (2002-11-01), Hansson et al.
patent: 2001/0038862 (2001-11-01), Luo et al.
patent: 2001/0053839 (2001-12-01), Noishiki et al.
patent: 2001/0056079 (2001-12-01), Hansson et al.
patent: 2002/0018813 (2002-02-01), Burns et al.
patent: 2002/0048563 (2002-04-01), Baetge et al.
patent: 2002/0064551 (2002-05-01), Edwards et al.
patent: 2002/0064559 (2003-05-01), Lee et al.
patent: WO 92/13553 (1992-08-01), None
patent: WO 02/10221 (2002-02-01), None
Ishihara M, Saito Y, Yura H, Ono K, Ishikawa K, Hattori H, Akaike T, Kurita D.J: Heparin-carrying polystyrene to mediate cellular attachment and growth via interaction with growth factors. Biomed Mater Res May; 50(2): 144-52 (2000).
Cox, M.D., David A., et al., “Effect of Local Delivery of Heparin and Methotrexate on Neointimal Proliferation in Stented Procine Coronary Arteries”,Coronary Artery Disease, Current Science, vol. 3, (1992),237-248.
Edelman, Elazer R., et al., “Basic Fibroblast Growth Factor Enhances the Coupling of Intimal Hyperplasia and Proliferation of Vasa Vasorum in Injured Rat Arteries”,J. Clin. Invest., vol. 89, (Feb. 1992),465-473.
Ksander, George A., et al., “Exogenous Transforming Growth Factor-Beta 2 Enhances Connective Tissue formation and Wound Strength in Guinea Pig Dermal Wounds Healing by Secondary Intent”,Ann. Surg., (Mar. 1990),288-294.
Sellke, Frank W., “Therapeutic Angiogenesis with Basic Fibroblast Growth Factor: Technique and Early Results”,Ann. Thorac Surg 1998:65:1540-4, (1988), 1540-1544.
BioSurface Engineering Technologies, Inc.
Maier Leigh C.
Peacock & Myers, P.C.
Slusher Stephen A.
Vilven Janeen
LandOfFree
Bioactive medical films does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioactive medical films, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioactive medical films will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3839555